Projects per year
Fingerprint
Dive into the research topics where Division of Biochemistry (Pharmacy) is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
NK Hücrelerinin SEB ile Yeniden Programlanması Fonksiyonel ve Moleküler Yanıtların Analizi
Türk, S. (CoI)
25/06/25 → …
Project: Research › SRP
-
Mikrobiyal OMVler ile NK92 Hücrelerinin Yeniden Programlanması Hücre İçi Dinamiklere Yeni Bir Bakış
Türk, S. (CoI)
25/06/25 → …
Project: Research › SRP
-
Stafilokokal Enterotoksin A Aracılığıyla NK Hücre İmmünmodülasyonunun Deneysel Analizi
Türk, S. (CoI)
25/06/25 → …
Project: Research › SRP
-
A pathway from the anterior cingulate cortex to the lateral habenula controls chronic pain-induced depression in male mice
Journée, S. H., Mathis, V. P., Waegaert, R., Ozkan, S., Langlois, E., Ortiz-Teba, P., Ayazgok, B., Becker, L. J., Gaikwad, M., Barrot, M., Hugel, S., Harsan, L., Lutz, P. E. & Yalcin, I., 21 Jan 2026, In: Neuropsychopharmacology. 51, 7, p. 1267-1278 12 p., PMID 8904907.Research output: Contribution to journal › Article › peer-review
Open Access -
Factorial design-guided optimization of liposome/lipoplex fabrication using microfluidic chip technology for anti-fibrotic wound healing
Sezer, A., Arıca, B., Baysal, P. & Yabanoğlu-Ciftci, S., Nov 2026, In: Journal of Drug Delivery Science and Technology. 125, 108694.Research output: Contribution to journal › Article › peer-review
-
Impact of Prior T-DM1 Exposure on the Efficacy of Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer
Kemik, F., Sahin, T. K., Ozcelik, H., Sezer, A., Basaran, G., Biter, S., Erdem, D., Tunbekici, S., Oruc, A., Guren, A. K., Kaban, K., Aykan, M. B., Ekinci, O. B., Onur, I. D., Kalem, A., Altunok, O., Seyyar, M., Guney, B., Akdogan, O. & Yazici, M. & 25 others, , 17 Feb 2026, In: Clinical Cancer Research. 32, 3 p.Research output: Contribution to journal › Meeting Abstract › peer-review